PUMA BIOTECHNOLOGY INC shareholders Q2 2023

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 70 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

PUMA BIOTECHNOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$6,326,1624.10%
Eversept Partners, LP 1,658,195$5,853,4280.49%
Camber Capital Management LP 4,235,000$14,9500.49%
Hillsdale Investment Management Inc. 802,903$2,834,2480.26%
Affinity Asset Advisors, LLC 202,349$714,2920.25%
Kynam Capital Management, LP 473,070$1,669,9370.23%
GLOBEFLEX CAPITAL L P 561,530$1,982,2010.22%
CORNERCAP INVESTMENT COUNSEL INC 126,963$448,1790.08%
RICE HALL JAMES & ASSOCIATES, LLC 371,034$1,309,7500.07%
XTX Topco Ltd 78,450$276,9290.05%
Patriot Financial Group Insurance Agency, LLC 65,000$229,4500.04%
GSA CAPITAL PARTNERS LLP 114,698$4050.04%
ACADIAN ASSET MANAGEMENT LLC 1,874,123$6,6140.03%
Prospera Financial Services Inc 108,448$382,8010.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,400$523,8520.01%
Crestline Management, LP 32,639$115,2160.01%
PDT Partners, LLC 21,946$77,4690.01%
Renaissance Technologies 1,758,013$6,2060.01%
CAXTON ASSOCIATES LP 16,247$57,3520.01%
MILLENNIUM MANAGEMENT LLC 2,806,254$9,906,0770.01%
External links

This page lists PUMA BIOTECHNOLOGY INC's shareholders in Q2 2023. To view PUMA BIOTECHNOLOGY INC's shareholder history, click here.